NCT06024161

Brief Summary

The study is a nationwide, register-based cohort survey study. The objective of this study is to investigate whether weight change is associated with the incidence of persistent postoperative pain following total hip arthroplasty and knee arthroplasty across non-obese and obese and patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 6, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
Last Updated

September 6, 2023

Status Verified

August 1, 2023

Enrollment Period

5 months

First QC Date

August 29, 2023

Last Update Submit

August 29, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Moderate/Severe Persistent Postoperative Pain

    The primary outcome is the number of patients with moderate or severe persistent postsurgical pain in the operated hip or knee, defined as patients with a numerical rating scale (NRS) score higher than 3. The outcome will be presented as Odd Ratio (OR) with its' corresponding 95% Confidence Interval (CI)

    11-15 months postsurgically

Secondary Outcomes (6)

  • Satisfaction

    11-15 months postsurgically

  • Willingness to repeat the surgery

    11-15 months postsurgically

  • Frequent pain

    11-15 months postsurgically

  • Use of analgaesic

    11-15 months postsurgically

  • Interference with daily activities

    11-15 months postsurgically

  • +1 more secondary outcomes

Study Arms (3)

Weight gainers

Weight gain 11-15 months after arthroplasty

Other: Weight gain

Weight losers

Weight loss11-15 months after arthroplasty

Other: Weight loss

Weight unchanged

Weight unchanged 11-15 months after arthroplasty

Other: Weight unchanged

Interventions

≥5% weight gain

Weight gainers

≥5% weight loss after arthroplasty

Weight losers

\<5% weight change after arthroplasty

Weight unchanged

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be identified based on the NOMESCO (Nordic Medico-Statistical Committee) Classification of Surgical Procedures from the the Danish National Patient Register by using SKS-code the codes for THA patients will be SKS-code DM16 \[hip osteoarthritis\] + KNFB20 or KNFB30 or KNFB40\[Primary Total Hip Arthroplasty\]. For total knee arthroplasty (TKA), SKS-code DM17 \[knee osteoarthritis\] + KNGB20, KNGB30 or KNGB40 \[primary total knee arthroplasty\]. For medial unicompartmental knee arthroplasty (UKA), SKS-code DM17 \[knee osteoarthritis\] + KNGB01 or KNGB11 \[primary medial unicompartmental knee arthroplasty\].

You may qualify if:

  • \- Patients operated with primary hip or knee arthroplasty for osteoarthritis 11-15 months before survey distribution

You may not qualify if:

  • Legally incompetent citizens, i.e., persons with a legal guardian, will not be asked to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, PostoperativeWeight LossWeight GainObesity

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsBody Weight ChangesBody WeightOverweightOvernutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Søren Overgaard, MD,DMSc,Prof

    Department of orthopedic surgery, Bispebjerg University Hospital, Denmark

    STUDY DIRECTOR

Central Study Contacts

Saber M. Saber, MD

CONTACT

Jens Laigaard, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
15 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD fellow

Study Record Dates

First Submitted

August 29, 2023

First Posted

September 6, 2023

Study Start

November 1, 2023

Primary Completion

March 31, 2024

Study Completion

November 30, 2024

Last Updated

September 6, 2023

Record last verified: 2023-08